[ITCI] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[ITCI] Intra-Cellular Therapies, Inc.
Announcement Date
22-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 45.49%
Quarter Report
ITCI's Result
ITCI's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 462,175 249,132 81,708 22,531 61 0 246 251.07%
PBT -139,038 -256,250 -284,120 -226,992 -147,721 -155,126 -98,834 5.85%
Tax 636 6 6 14 2 2 -1,061 -
NP -139,674 -256,256 -284,126 -227,006 -147,722 -155,127 -97,773 6.12%
Tax Rate - - - - - - - -
Total Cost 601,849 505,388 365,834 249,536 147,783 155,127 98,019 35.30%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -30.22 -102.86 -347.73 -1,007.54 -243,713.69 0.00 -39,771.64 -69.77%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.46 -2.72 -3.50 -3.23 -2.68 -2.84 -2.12 -6.02%
EPS Diluted -1.46 -2.72 -3.50 -3.23 -2.68 -2.84 -2.12 -6.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.